Found 8 hits for monomerid = 50311925 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Tyrosine-protein kinase Lck
(Homo sapiens (Human)) | BDBM50311925
(CHEMBL1075628 | N-(3-(1-(6-aminopyrimidin-4-yl)-1H...)Show SMILES CN1CCN(Cc2cc(nn2C(C)(C)C)C(=O)Nc2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)CC1 Show InChI InChI=1S/C32H39N11O/c1-21-10-11-22(36-30(44)26-17-23(43(39-26)32(2,3)4)19-41-14-12-40(5)13-15-41)16-25(21)38-31-37-24-8-6-7-9-27(24)42(31)29-18-28(33)34-20-35-29/h6-11,16-18,20H,12-15,19H2,1-5H3,(H,36,44)(H,37,38)(H2,33,34,35) | PDB
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of LCK |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Insulin receptor
(Homo sapiens (Human)) | BDBM50311925
(CHEMBL1075628 | N-(3-(1-(6-aminopyrimidin-4-yl)-1H...)Show SMILES CN1CCN(Cc2cc(nn2C(C)(C)C)C(=O)Nc2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)CC1 Show InChI InChI=1S/C32H39N11O/c1-21-10-11-22(36-30(44)26-17-23(43(39-26)32(2,3)4)19-41-14-12-40(5)13-15-41)16-25(21)38-31-37-24-8-6-7-9-27(24)42(31)29-18-28(33)34-20-35-29/h6-11,16-18,20H,12-15,19H2,1-5H3,(H,36,44)(H,37,38)(H2,33,34,35) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 818 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of Tel-fused InsR expressed in mouse BAF3 cells |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Proto-oncogene tyrosine-protein kinase Src
(Homo sapiens (Human)) | BDBM50311925
(CHEMBL1075628 | N-(3-(1-(6-aminopyrimidin-4-yl)-1H...)Show SMILES CN1CCN(Cc2cc(nn2C(C)(C)C)C(=O)Nc2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)CC1 Show InChI InChI=1S/C32H39N11O/c1-21-10-11-22(36-30(44)26-17-23(43(39-26)32(2,3)4)19-41-14-12-40(5)13-15-41)16-25(21)38-31-37-24-8-6-7-9-27(24)42(31)29-18-28(33)34-20-35-29/h6-11,16-18,20H,12-15,19H2,1-5H3,(H,36,44)(H,37,38)(H2,33,34,35) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 177 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of SRC |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase HCK
(Homo sapiens (Human)) | BDBM50311925
(CHEMBL1075628 | N-(3-(1-(6-aminopyrimidin-4-yl)-1H...)Show SMILES CN1CCN(Cc2cc(nn2C(C)(C)C)C(=O)Nc2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)CC1 Show InChI InChI=1S/C32H39N11O/c1-21-10-11-22(36-30(44)26-17-23(43(39-26)32(2,3)4)19-41-14-12-40(5)13-15-41)16-25(21)38-31-37-24-8-6-7-9-27(24)42(31)29-18-28(33)34-20-35-29/h6-11,16-18,20H,12-15,19H2,1-5H3,(H,36,44)(H,37,38)(H2,33,34,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of HCK |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase Lyn
(Homo sapiens (Human)) | BDBM50311925
(CHEMBL1075628 | N-(3-(1-(6-aminopyrimidin-4-yl)-1H...)Show SMILES CN1CCN(Cc2cc(nn2C(C)(C)C)C(=O)Nc2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)CC1 Show InChI InChI=1S/C32H39N11O/c1-21-10-11-22(36-30(44)26-17-23(43(39-26)32(2,3)4)19-41-14-12-40(5)13-15-41)16-25(21)38-31-37-24-8-6-7-9-27(24)42(31)29-18-28(33)34-20-35-29/h6-11,16-18,20H,12-15,19H2,1-5H3,(H,36,44)(H,37,38)(H2,33,34,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 88 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of Tel-fused LYN expressed in mouse BAF3 cells |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Proto-oncogene tyrosine-protein kinase Src
(Homo sapiens (Human)) | BDBM50311925
(CHEMBL1075628 | N-(3-(1-(6-aminopyrimidin-4-yl)-1H...)Show SMILES CN1CCN(Cc2cc(nn2C(C)(C)C)C(=O)Nc2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)CC1 Show InChI InChI=1S/C32H39N11O/c1-21-10-11-22(36-30(44)26-17-23(43(39-26)32(2,3)4)19-41-14-12-40(5)13-15-41)16-25(21)38-31-37-24-8-6-7-9-27(24)42(31)29-18-28(33)34-20-35-29/h6-11,16-18,20H,12-15,19H2,1-5H3,(H,36,44)(H,37,38)(H2,33,34,35) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 249 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of Tel-fused SRC expressed in mouse BAF3 cells |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50311925
(CHEMBL1075628 | N-(3-(1-(6-aminopyrimidin-4-yl)-1H...)Show SMILES CN1CCN(Cc2cc(nn2C(C)(C)C)C(=O)Nc2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)CC1 Show InChI InChI=1S/C32H39N11O/c1-21-10-11-22(36-30(44)26-17-23(43(39-26)32(2,3)4)19-41-14-12-40(5)13-15-41)16-25(21)38-31-37-24-8-6-7-9-27(24)42(31)29-18-28(33)34-20-35-29/h6-11,16-18,20H,12-15,19H2,1-5H3,(H,36,44)(H,37,38)(H2,33,34,35) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 63 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of Tel-fused KDR expressed in mouse BAF3 cells |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase Lck
(Homo sapiens (Human)) | BDBM50311925
(CHEMBL1075628 | N-(3-(1-(6-aminopyrimidin-4-yl)-1H...)Show SMILES CN1CCN(Cc2cc(nn2C(C)(C)C)C(=O)Nc2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)CC1 Show InChI InChI=1S/C32H39N11O/c1-21-10-11-22(36-30(44)26-17-23(43(39-26)32(2,3)4)19-41-14-12-40(5)13-15-41)16-25(21)38-31-37-24-8-6-7-9-27(24)42(31)29-18-28(33)34-20-35-29/h6-11,16-18,20H,12-15,19H2,1-5H3,(H,36,44)(H,37,38)(H2,33,34,35) | PDB
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of Tel-fused LCK expressed in mouse BAF3 cells |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |